RXI PHARMACEUTICALS CORPOROATION

Company

SELLAS Life Sciences Group, Inc.

Filed

April 15, 2008

Period of Report

December 31, 2007

Accession Number

0000950135-08-002535

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →